Lobenzarit disodium inhibits the constitutive NO–cGMP metabolic pathways. Possible involvement as an immunomodulatory drug

Lobenzarit disodtulIl (CCA) is a novel immunomodulatory drug useful in the treatment of chronic inflammations. Its principal mechanism of action seems to be through enhancing the T suppressor/T helper lymphocyte ratio. However, the molecular basis for these actions remains unclear. In this study it...

Descripción completa

Detalles Bibliográficos
Autores principales: Padrón, J., Rojas, A., Glaría, L., Caveda, L., Delgado, R., Torres, M., Martínez, O., López, E., Beltrán, A., Palacios, M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365655/
https://www.ncbi.nlm.nih.gov/pubmed/18475666
http://dx.doi.org/10.1155/S0962935195000597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365655/
https://www.ncbi.nlm.nih.gov/pubmed/18475666
http://dx.doi.org/10.1155/S0962935195000597

Ejemplares similares